MENU
PTGX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.65B
P/E Ratio
16.54
Total Cash
564M
Projected Growth
N/A
Total Debt
10.97M
Revenue
319.12M
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash/Share
9.57
Total Debt/Equity
N/A
Revenue/Share
5.16 USD as % of share price
Fundamentals
PTGX
Capitalization
2.65B
P/E Ratio
16.54
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash
564M
Total Cash/Share
9.57
Total Debt
11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.16%
Revenue
319M
ROE
N/A
Book Value
541M
P/B Ratio
4.89
Cash Flow
N/A
Earnings
2.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
13.73
Current Revenue Per Employee
33336.00
Dividends Per Share - Security
N/A
EBITDA
156M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
36.35
Shares Held By Institutions
2.91B
Shares Outstanding - Current
58.9M
Total Liabilities
73.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
104.928
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of disulfide-rich peptides
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com